Scarica l'app Stockscreener
0.8594
1.11%
0.0094
Dopo l'orario di chiusura:
.86
0.0006
+0.07%
Precedente Chiudi:
$0.85
Aprire:
$0.838
Volume 24 ore:
37,120
Relative Volume:
0.15
Capitalizzazione di mercato:
$28.70M
Reddito:
-
Utile/perdita netta:
$-10.21M
Rapporto P/E:
-1.4711
EPS:
-0.5842
Flusso di cassa netto:
-
1 W Prestazione:
-0.76%
1M Prestazione:
-17.37%
6M Prestazione:
-29.56%
1 anno Prestazione:
-23.27%
Intervallo 1D:
$0.838
$0.8726
Intervallo di 1 settimana:
$0.82
$0.91
Portata 52W:
$0.6801
$2.60
Neurosense Therapeutics Ltd Stock (NRSN) Company Profile
Nome
Neurosense Therapeutics Ltd
Settore
Industria
Telefono
-
Indirizzo
-
Compare NRSN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NRSN
Neurosense Therapeutics Ltd
|
0.8594 | 28.70M | 0 | -10.21M | 0 | -0.5842 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.34 | 119.23B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
745.77 | 78.84B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
700.45 | 43.35B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
313.41 | 41.57B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
284.05 | 31.51B | 5.36B | 287.73M | 924.18M | 2.5229 |
Neurosense Therapeutics Ltd Borsa (NRSN) Ultime notizie
NeuroSense Shareholders Approve Increase in Registered Share Capital - The Globe and Mail
[6-K] NeuroSense Therapeutics Ltd. Current Report (Foreign Issuer) | NRSN SEC FilingForm 6-K - Stock Titan
NeuroSense "PrimeC" Market size expansion of Several Folds by 2034 - openPR.com
This Strategy Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday - Benzinga
Roth/MKM initiates NeuroSense stock with buy on ALS drug potential - Investing.com Nigeria
Roth/MKM initiates NeuroSense stock with buy on ALS drug potential By Investing.com - Investing.com South Africa
Neurosense Therapeutics Ltd. Presents Long-Term Survival Data for Primec in Amyotrophic Lateral Sclerosis - marketscreener.com
Analysis Recap: Can NeuroSense Therapeutics Ltd Equity Warrant keep up with sector leadersMarket Sentiment Review & Free High Accuracy Swing Entry Alerts - baoquankhu1.vn
Long-Term Data From PARADIGM Trial Suggest Survival Benefit With PrimeC in ALS - Neurology Live
Buy Signal: What are NeuroSense Therapeutics Ltd Equity Warrants earnings expectationsSell Signal & Real-Time Market Sentiment Reports - baoquankhu1.vn
Will NeuroSense Therapeutics Ltd. stock continue upward momentumJuly 2025 Sentiment & Fast Entry High Yield Stock Tips - Naître et grandir
Insider Sell: What are the risks of holding NeuroSense Therapeutics Ltd Equity WarrantJuly 2025 Update & Capital Efficiency Focused Ideas - baoquankhu1.vn
Revenue Check: Whats the fair value of NeuroSense Therapeutics Ltd stockRisk Management & Fast Exit and Entry Trade Guides - baoquankhu1.vn
Published on: 2026-03-06 17:33:43 - baoquankhu1.vn
NRSN SEC FilingsNeurosense Therapeutics Ltd 10-K, 10-Q, 8-K Forms - Stock Titan
Revenue Check: Is NeuroSense Therapeutics Ltd Equity Warrant forming a bullish divergence2025 Technical Patterns & Verified Momentum Stock Ideas - baoquankhu1.vn
IANS - IANS
Book value per share of Neurosense Therapeutics Ltd. – FWB:H1Z - TradingView
Buyback Watch: Is NeuroSense Therapeutics Ltd Equity Warrant stock undervalued right now2025 Market WrapUp & Verified Momentum Watchlists - baoquankhu1.vn
NRSN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Panic Selling: Is NeuroSense Therapeutics Ltd still a buy after recent gains2025 Buyback Activity & Daily Volume Surge Signals - baoquankhu1.vn
Activity Recap: Is NeuroSense Therapeutics Ltd Equity Warrant stock undervalued right nowJuly 2025 Reactions & Long-Term Safe Investment Plans - baoquankhu1.vn
Earnings Miss: What is VCICs valuation compared to sector2025 Momentum Check & Real-Time Price Movement Reports - baoquankhu1.vn
Gap Down: Is NeuroSense Therapeutics Ltd Equity Warrant benefiting from interest rate changesTrade Exit Summary & Weekly High Return Stock Forecasts - baoquankhu1.vn
Why is NeuroSense Therapeutics Ltd. stock going downMarket Volume Summary & Daily Risk Controlled Trade Plans - mfd.ru
What are NeuroSense Therapeutics Ltd. Equity Warrant’s recent SEC filings showingStop Loss & Weekly High Conviction Ideas - mfd.ru
ALS drug PrimeC cuts death risk by 65% - Longevity.Technology
Is NeuroSense Therapeutics Ltd. Equity Warrant stock safe for conservative investorsPortfolio Value Report & Long-Term Safe Investment Ideas - mfd.ru
Aug Chart Watch: Does NeuroSense Therapeutics Ltd Equity Warrant align with a passive investing strategyJuly 2025 Opening Moves & Safe Capital Investment Plans - baoquankhu1.vn
NeuroSense Therapeutics (NRSN) Stock Price, News & Analysis - MarketBeat
NeuroSense Announces Statistically Significant 65% Reduction in Risk of Death and Greater than 14-Month Median Survival Benefit with PrimeC in ALS - Finviz
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
NeuroSense Reports 65% Lower Mortality Risk and 14-Month Survival Gain for PrimeC in ALS Trial - TipRanks
Published on: 2026-02-18 21:38:58 - baoquankhu1.vn
ALS trial: NeuroSense drug extends survival by 14 months, cuts deaths 65% - Stock Titan
Buyout Rumor: Whats the analyst consensus on Invesco Mortgage Capital IncPortfolio Gains Report & Weekly High Return Stock Forecasts - baoquankhu1.vn
How NeuroSense Therapeutics Ltd. stock reacts to global recession fearsJuly 2025 Short Interest & Verified Stock Trade Ideas - mfd.ru
NRSN Should I Buy - Intellectia AI
What are the risks of holding NeuroSense Therapeutics Ltd. Equity WarrantWeekly Earnings Recap & Reliable Volume Spike Trade Alerts - mfd.ru
NeuroSense Provides Business Update and Progress for the First Half of 2025 - Intellectia AI
Why NeuroSense Therapeutics Ltd. Equity Warrant stock could be next big winner2025 EndofYear Setup & Weekly High Return Forecasts - mfd.ru
Is NeuroSense Therapeutics Ltd. stock supported by strong fundamentalsPortfolio Gains Summary & Weekly High Conviction Trade Ideas - mfd.ru
Will NeuroSense Therapeutics Ltd. (H1Z) stock enhance shareholder valueWeekly Investment Report & Pattern Based Trade Signal System - mfd.ru
NeuroSense Therapeutics Calls March 10, 2026 Special Meeting to Approve Share Capital Increase - TipRanks
Published on: 2026-02-13 23:05:19 - baoquankhu1.vn
Is NeuroSense Therapeutics Ltd. a momentum stock2025 Technical Patterns & Weekly Top Gainers Alerts - mfd.ru
Aug Chart Watch: Is NeuroSense Therapeutics Ltd Equity Warrant benefiting from interest rate changesGlobal Markets & Real-Time Stock Price Movement Reports - baoquankhu1.vn
Is NeuroSense Therapeutics Ltd. Equity Warrant forming a bullish divergenceWeekly Trade Summary & Weekly Chart Analysis and Guides - mfd.ru
Wall Street Recap: How do insiders feel about Prelude Therapeutics IncorporatedQuarterly Performance Summary & Free High Return Stock Watch Alerts - baoquankhu1.vn
MACD Signal: Whats the fair value of NeuroSense Therapeutics Ltd stockAnalyst Upgrade & Weekly Momentum Picks - baoquankhu1.vn
Is NeuroSense Therapeutics Ltd. Equity Warrant stock recession proof2025 Performance Recap & High Return Trade Opportunity Guides - mfd.ru
Neurosense Therapeutics Ltd Azioni (NRSN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.48%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):